Literature DB >> 8863371

Nosocomial cerebral aspergillosis: a report of 3 cases.

C Darras-Joly1, B Veber, J P Bedos, B Gachot, B Regnier, M Wolff.   

Abstract

Cerebral aspergillosis carries a mortality rate close to 100%, especially in immunocompromised patients. We describe 3 patients who contracted cerebral aspergillosis after neurosurgery, 2 of whom survived after exhaustive surgical treatment and medical treatment with high doses of amphotericin B (once liposomal), 5-fluorocytosine and itraconazole. We review the few non-fatal cases of cerebral aspergillosis reported. We consider that surgical excision must be complete and repeated if necessary, always in combination with medical treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8863371     DOI: 10.3109/00365549609027182

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

Review 1.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

Review 2.  CNS aspergillosis: recognition, diagnosis and management.

Authors:  Markus Ruhnke; Grzegorz Kofla; Kirsten Otto; Stefan Schwartz
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  Association between a Primitive Brain Tumor and Cerebral Aspergillosis.

Authors:  Siegfried Hélage; Charles Duyckaerts; Danielle Seilhean; Jean-Jacques Hauw; Jacques Chiras
Journal:  Case Rep Med       Date:  2012-02-20

Review 4.  Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases.

Authors:  Spinello Antinori; Mario Corbellino; Luca Meroni; Federico Resta; Salvatore Sollima; Massimo Tonolini; Anna Maria Tortorano; Laura Milazzo; Lorenzo Bello; Elisa Furfaro; Massimo Galli; Claudio Viscoli
Journal:  J Infect       Date:  2012-11-21       Impact factor: 6.072

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.